Evidence map›Paper›PMID 8215355›Full record

ArticleApplied and environmental microbiology1993

Construction of a recombinant wine yeast strain expressing beta-(1,4)-endoglucanase and its use in microvinification processes.

J A Pérez-González, R González, A Querol, J Sendra, D Ramón

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Truth in wine yeast.Microbial biotechnology · 2022
    Review
  2. Screening of enzymatic activities within different enological non-Journal of food science and technology · 2017
    Article
  3. Cultivable psychrotolerant yeasts associated with Antarctic marine sponges.World journal of microbiology & biotechnology · 2013
    Article
  4. Flavour-active wine yeasts.Applied microbiology and biotechnology · 2012
    Review
  5. Wine flavor and aroma.Journal of industrial microbiology & biotechnology · 2011
    Review
  6. Article
  7. Article
  8. Article
  9. Microbial cellulose utilization: fundamentals and biotechnology.Microbiology and molecular biology reviews : MMBR · 2002
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

J A Pérez-GonzálezUnidad de Bioingeniería, Instituto de Agroquímica y Tecnología de los Alimentos, Consejo Superior de Investigaciones Científicas, Valencia, Spain.
R González
A Querol
J Sendra
D Ramón

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A genetic transformation system for an industrial wine yeast strain is presented here. The system is based on the acquisition of cycloheximide resistance and is a direct adaptation of a previously published procedure for brewing yeasts (L. Del Pozo, D. Abarca, M. G. Claros, and A. Jiménez, Curr. Genet. 19:353-358, 1991). Transformants arose at an optimal frequency of 0.5 transformant per microgram of DNA, are stable in the absence of selective pressure, and produce wine in the same way as the untransformed industrial strain. By using this transformation protocol, a filamentous fungal beta-(1,4)-endoglucanase gene has been expressed in an industrial wine yeast under the control of the yeast actin gene promoter. Endoglucanolytic wine yeast secretes the fungal enzyme to the must, producing a wine with an increased fruity aroma.

Indexed as

Food MicrobiologyWineBase SequenceCellulaseDNA, FungalFood TechnologyGene Expression Regulation, FungalGenes, FungalMolecular Sequence DataRecombination, GeneticSaccharomyces cerevisiaeTransformation, GeneticTrichodermaCellulaseDNA, Fungal

Identifiers

PMID8215355
PMCPMC182369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.